Company Filing History:
Years Active: 2019
Title: Sagi Sheinkman: Innovator in Androgen-Dependent Disorder Treatments
Introduction
Sagi Sheinkman is a notable inventor based in Netanya, Israel. He has made significant contributions to the field of medical treatments, particularly focusing on androgen-dependent disorders. His innovative work has led to the development of a unique patent that addresses these health issues.
Latest Patents
Sagi Sheinkman holds a patent for a composition and method for treating androgen-dependent disorders. This patent, titled "Composition and method for treating androgen-dependent disorders," involves chimeric polypeptides that include a dihydrotestosterone (DHT) reductase moiety, such as 3 alpha-hydroxysteroid dehydrogenase (3α-HSD), fused to a signal peptide moiety. The invention also encompasses polynucleotides encoding the chimeric polypeptide and compositions that include at least one microorganism cell capable of secreting the chimeric polypeptide. The methods and kits provided by this patent aim to treat, prevent, or ameliorate androgen-dependent disorders, including androgenic alopecia. Sagi Sheinkman has 1 patent to his name.
Career Highlights
Sagi Sheinkman is associated with the Technion Research & Development Foundation Limited, where he continues to work on innovative solutions in the medical field. His research and development efforts have positioned him as a key figure in the advancement of treatments for androgen-dependent conditions.
Collaborations
Throughout his career, Sagi has collaborated with talented individuals such as Roee Amit and Alexey Tomsov. These partnerships have contributed to the success of his projects and the development of effective treatments.
Conclusion
Sagi Sheinkman is a pioneering inventor whose work in treating androgen-dependent disorders has the potential to make a significant impact in the medical community. His innovative approaches and collaborations highlight the importance of research and development in addressing health challenges.